NEW YORK (GenomeWeb) – Quanterix reported after the close of the market on Wednesday that its second quarter revenues were up 66 percent year over year.

The company posted Q2 revenues of $8.6 million, up from $5.2 million in Q2 2017 and above the consensus Wall Street estimate of $7.9 million.

Q2 product revenues rose 56 percent to $5.2 million from $3.3 million in Q2 2017. Service and other revenues doubled to $3.2 million from $1.6 million in the prior-year second quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

This year's Breakthrough Prize winners include a pair that developed a therapy for spinal muscular atrophy.

The New York Times reports on how white supremacists misconstrue genetic research, concerning many geneticists.

Researchers find that people's genetics influence their success at university, but that it is not the only factor.

In Nature this week: approach to identify genetic variants that affect trait variability, application of read clouds to microbiome samples, and more.